CELL C HOLDINGS LIMITED - Dealings in securities by an associate of a director
What this filing means
A director's associate purchased a negligible amount of Cell C shares on the open market.
The husband of a Cell C director bought a very small number of shares in the company. Because the amount is so tiny, it doesn't change anything for other investors.
Bull case
- The transaction involves on-market purchases of ordinary shares by an associate of the director, indicating a continued, albeit small, accumulation of equity.
- The latest purchase was executed at R28.50 per share, demonstrating a willingness to acquire shares outright on the open market.
Bear case
- The transactions are highly immaterial in scale, with the February 2026 purchase amounting to only 53 shares.
- The financial value of the dealings is negligible, providing no significant signal of insider conviction or strategic support for the share price.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
An associate of director El Kope purchased ordinary shares on the open market in November 2025 and February 2026. The total combined value of these transactions is approximately R15,000, making them highly immaterial in scale. This does not establish any meaningful change in insider conviction or strategic direction. Investor Takeaway: This is a routine administrative disclosure with no bearing on the equity thesis. Rating Context: This is a technical/administrative event with no direct equity impact.
Routine filing. No equity signal. No portfolio action required.
Decision framework
Current stance: Filing Neutral
Key drivers
- The transaction involves on-market purchases of ordinary shares by an associate of the director, indicating a continued, albeit small, accumulation of equity.
- The latest purchase was executed at R28.50 per share, demonstrating a willingness to acquire shares outright on the open market.
Key risks
- The transactions are highly immaterial in scale, with the February 2026 purchase amounting to only 53 shares.
- The financial value of the dealings is negligible, providing no significant signal of insider conviction or strategic support for the share price.
What would change the view
- Guidance and cash-flow quality both improve materially from current baseline.
- Subsequent filings remove current uncertainty and confirm durable execution.
- Market structure/positioning shifts enough to support a directional thesis.
Evidence from the filing
The transaction involves on-market purchases of ordinary shares by an associate of the director, indicating a continued, albeit small, accumulation of equity.
“Nature of transaction : On market purchase of securities by an associate”
The latest purchase was executed at R28.50 per share, demonstrating a willingness to acquire shares outright on the open market.
“Purchase price per share : R28.50”
The transactions are highly immaterial in scale, with the February 2026 purchase amounting to only 53 shares.
“Number of securities : 53”
The financial value of the dealings is negligible, providing no significant signal of insider conviction or strategic support for the share price.
“Total value of transaction : R1,510.50”
More on Cell C Holdings Limited
Related filings
More from CCD
Other Director Dealings
- ISOASP ISOTOPES INC - Form 4 statement of changes in beneficial ownership
- AFEA E C I LIMITED - Dealings in securities by directors, prescribed officers and the group company secretary
- ITEITALTILE LIMITED - Dealings in Securities by Directors and Intragroup Acquisition of Shares
- HMNHAMMERSON PLC - Notification of Transactions of Directors and PDMRs
- SSSSTOR-AGE PROPERTY REIT LIMITED - Dealings in Securities